Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

China · Delayed Price · Currency is CNY

6.73

-0.16 (-2.32%)

Jul 30, 2026, 11:29 AM CST

8.37% (1Y)

Market Cap	3.81B +11.0%
Revenue (ttm)	1.78B +1.1%
Net Income	61.07M +98.3%
EPS	0.11 +97.9%
Shares Out	552.92M
PE Ratio	62.58
Forward PE	n/a
Dividend	0.01 (0.20%)
Ex-Dividend Date	Jan 9, 2026

Volume	6,545,700
Open	6.86
Previous Close	6.89
Day's Range	6.71 - 6.95
52-Week Range	6.06 - 9.44
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the manufacture and sale of pharmaceutical preparations and Chinese herbal medicine slices in China. The company offers Shuanghuanglian oral liquid series, Shuangjinlian mixture, children's heat-clearing and cough-relieving oral liquid series, pediatric antipyretic oral liquid, Jiaweishanxiang Zhengqi compound preparation, honeysuckle dew, danshen oral liquid, Shengmai Yin, pediatric compound chicken gizzard chewable tablets, Chewable tablets, huperzine A tablets, Wuzi Yanzong oral liquid, co... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 2,084

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600222

Full Company Profile

Financial Performance

In 2025, SHA:600222's revenue was 1.76 billion, a decrease of -9.46% compared to the previous year's 1.94 billion. Earnings were 60.00 million, an increase of 18.74%.

Financial Statements